Company / Cash & Equivalents
Morgan Stanley Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$111.7B
FY2025
5-year range
$89.2B / $128.1B
FY2021-FY2025
Trend
+6.0%
vs FY2024
Sector context
#2 of 255
Financials
What the data says
Among 255 Financials companies, Morgan Stanley is in the top 1% for cash & equivalents. Cash & Equivalents has fluctuated over the past 9 years, ranging from $47.0B in FY2016 to $128.1B in FY2022.
Based on SEC 10-K filings.
$111.7B in FY2025 with a 5-year CAGR of +1.1%. Ranks 2nd among 255 companies in Financials.
Improved from $89.2B to $111.7B over the past 2 years.
Financials sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -4.5%
- 5-Year CAGR
- +1.1%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in FinancialsTop 1% of 255This company $111.7B Sector average $2.8B
▼
+3839.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.1%, indicating consistent growth.
- In FY2025, cash & equivalents increased 6.0% year-over-year.
- Ranks #2 out of 255 companies in the Financials sector.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.7B | +6.0% |
| FY2024 | $105.4B | +18.1% |
| FY2023 | $89.2B | -30.4% |
| FY2022 | $128.1B | +0.3% |
| FY2021 | $127.7B | +20.9% |
| FY2020 | $105.7B | - |
| FY2019 | - | - |
| FY2018 | $80.4B | -6.0% |
| FY2017 | $85.6B | +82.1% |
| FY2016 | $47.0B | -21.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026